Biohaven Ltd (NYSE: BHVN) on Monday, soared 8.76% from the previous trading day, before settling in for the closing price of $28.54. Within the past 52 weeks, BHVN’s price has moved between $26.80 and $59.53.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
The company achieved an average annual earnings per share of 26.44%. With a float of $89.15 million, this company’s outstanding shares have now reached $101.22 million.
In an organization with 256 employees, it is important to assess its efficiency. In terms of profitability, gross margin is 0.0%, operating margin of 0.0%, and the pretax margin is 0.0%.
Biohaven Ltd (BHVN) Insider and Institutional Ownership
Observing investor behavior towards Biotechnology industry stocks is more important than anything else. The insider ownership of Biohaven Ltd is 12.66%, while institutional ownership is 90.65%. The most recent insider transaction that took place on Mar 04 ’25, was worth 996,238. In this transaction Director of this company bought 32,700 shares at a rate of $30.47, taking the stock ownership to the 2,320,571 shares. Before that another transaction happened on Dec 30 ’24, when Company’s Director bought 29,000 for $35.94, making the entire transaction worth $1,042,393. This insider now owns 2,368,741 shares in total.
Biohaven Ltd (BHVN) Latest Financial update
According to the Wall Street analysts, stocks earnings will be around 26.44% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 22.04% during the next five years compared to -49.78% drop over the previous five years of trading.
Biohaven Ltd (NYSE: BHVN) Trading Performance Indicators
Biohaven Ltd (BHVN) is currently performing well based on its current performance indicators. A quick ratio of 3.49 was reported for the most recent quarter.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -9.39, a number that is poised to hit -1.70 in the next quarter and is forecasted to reach -5.83 in one year’s time.
Technical Analysis of Biohaven Ltd (BHVN)
Let’s dig in a bit further. During the last 5-days, its volume was 0.82 million. That was inferior than the volume of 0.98 million it reported in year-ago period. As of the previous 9 days, the stock’s Stochastic %D was 60.52%. Additionally, its Average True Range was 1.96.
During the past 100 days, Biohaven Ltd’s (BHVN) raw stochastic average was set at 14.56%, which indicates a significant decrease from 83.10% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 63.21% in the past 14 days, which was higher than the 59.86% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $35.67, while its 200-day Moving Average is $40.16. However, in the short run, Biohaven Ltd’s stock first resistance to watch stands at $31.82. Second resistance stands at $32.60. The third major resistance level sits at $34.12. If the price goes on to break the first support level at $29.52, it is likely to go to the next support level at $28.00. The third support level lies at $27.22 if the price breaches the second support level.
Biohaven Ltd (NYSE: BHVN) Key Stats
Market capitalization of the company is 3.17 billion based on 102,065K outstanding shares. Right now, sales total 0 K and income totals -846,420 K. The company made 0 K in profit during its latest quarter, and -186,840 K in sales during its previous quarter.
